Allgens(SH:688613) Sou Hu Cai Jing·2025-07-26 18:36Core Viewpoint - OssaNova, a product of Aojing Medical, has received registration certification in Vietnam, which is expected to aid the company's expansion into overseas markets, although the specific impact on performance remains uncertain [1][3]. Company Announcements Summary - Aojing Medical has announced that its artificial bone repair material received registration certification from the Vietnamese Ministry of Health, effective from July 16, 2025, with a permanent validity [3]. - The registration number for the product is 2502543ĐKLH/BYT-HTTB, classified as a Class D (high-risk medical device) [3]. - The OssaNova artificial bone repair material is primarily used for bone defect repair in oral or plastic surgery where there are no contraindications for bone grafting, and it has previously received registration in China and Indonesia [3]. - The company has decided to cancel its fundraising account at Industrial Bank due to adjustments in the implementation subject and location of fundraising projects, with the cancellation date set for July 23, 2025 [2][3]. - The termination of the related four-party regulatory agreement has been communicated to the sponsor institution Huatai United and the sponsoring representative [3].